The Longevity Market Is Leaving $350 Billion on the Table in Unmet Demand From Women in Perimenopause and Menopause
Article excerpt
Highlighted: the sentence this signal was extracted from
BOSTON, Sept. 22, 2026 /PRNewswire/ -- Women in perimenopause or menopause are the most engaged, highest-spending longevity consumers, yet their needs remain underserved. New research from Boston Consulting Group (BCG) puts a number on that care gap: applied across the roughly 1 billion women worldwide who are in menopause and are already spending on longevity, the unmet demand adds up to an estimated $350 billion. This insight comes from BCG's 2026 global study on longevity, titled The $350 Billion Longevity Mismatch in Women's Health . The report, conducted for the St. Moritz Longevity Forum, draws on a survey of 10,608 people across 12 countries. Among the report's findings: "Companies wait for menopause before they start talking to women about long-term health, but the real window opens about a decade earlier," said Parul Bajaj, a BCG managing director and partner, and a coauthor of the report. "Treating those hormonal shifts in the mid-30s as short-term symptoms, rather than the turning point they actually are, is one of the biggest blind spots in how the market serves women today." Women's Health Needs Persistently Go Undiagnosed and Undertreated The care gap isn't limited to menopause. BCG's survey found that just 63% of women consult a doctor about hormone-related issues such as PCOS, endometriosis, or menopause, compared with 78% who do so for cardiovascular...
Keep reading with a free account
The rest of this article, and every signal for BCG, is in your free account.
